Table 2_QSAR-guided discovery of novel KRAS inhibitors for lung cancer therapy.xlsx
Introduction<p>KRAS mutations are key oncogenic drivers in lung cancer, yet effective pharmacological targeting has remained a major challenge due to the protein's elusive and dynamic binding pockets. Computational modeling offers a promising route to identify novel inhibitors with improv...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , , , |
| Published: |
2025
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!